Vical Incorporated (NASDAQ:VICL) posted its quarterly earnings data on Monday. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.02), Bloomberg Earnings reports. Vical had a negative return on equity of 26.09% and a negative net margin of 92.02%.

Shares of Vical (NASDAQ:VICL) opened at 2.38 on Monday. The company’s market capitalization is $27.14 million. Vical has a 1-year low of $2.05 and a 1-year high of $3.70. The firm has a 50-day moving average of $2.54 and a 200 day moving average of $2.45.

ILLEGAL ACTIVITY WARNING: “Vical Incorporated (VICL) Posts Earnings Results, Misses Expectations By $0.02 EPS” was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at

A number of research firms have recently issued reports on VICL. ValuEngine downgraded shares of Vical from a “sell” rating to a “strong sell” rating in a report on Friday, September 1st. HC Wainwright set a $9.00 price objective on shares of Vical and gave the stock a “buy” rating in a report on Wednesday, August 9th. Finally, Ifs Securities reaffirmed an “outperform” rating on shares of Vical in a report on Tuesday, August 8th.

Vical Company Profile

Earnings History for Vical (NASDAQ:VICL)

Receive News & Ratings for Vical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vical Incorporated and related companies with's FREE daily email newsletter.